NCT04896034View on ClinicalTrials.gov

Efficacy of the Photobiomodulation on the Pelvi-perineal Pain in Immediate Post-partum Situation

NACompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

May 12, 2023

Conditions
Pelvic Pain
Interventions
DEVICE

MILTA Device

Patients in MILTA Device group will each receive 2 sessions of PBM in this study, the first session within 24 hours of delivery, and the second session 24 hours after the first session.

DEVICE

" control 1 fake MILTA device"

Patients in group control 1 will each receive 2 sessions of PBM in this study, the first session within 24 hours of delivery, and the second session 24 hours after the first session.

Trial Locations (1)

63110

Clinique la Chataigneraie, Beaumont

Sponsors

Lead Sponsor

Elsan
All Listed Sponsors
lead

Elsan

OTHER

NCT04896034 - Efficacy of the Photobiomodulation on the Pelvi-perineal Pain in Immediate Post-partum Situation | Biotech Hunter | Biotech Hunter